Normal view MARC view ISBD view

The prophylactic use of fluconazole 50 vs. 100 mg daily in haematological malignancies.

Huijgens, P C

The prophylactic use of fluconazole 50 vs. 100 mg daily in haematological malignancies. [electronic resource] - European journal of cancer (Oxford, England : 1990) 1993 - 926-7 p. digital

Publication Type: Letter

ISSN: 0959-8049

Standard No.: 10.1016/s0959-8049(05)80444-7 doi

Subjects--Topical Terms:
Adolescent
Adult
Aged
Candidiasis, Oral--prevention & control
Female
Fluconazole--therapeutic use
Humans
Leukemia, Myeloid--complications
Lymphoma--complications
Male
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma--complications

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)